Supplementary Tables from A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment

Autor: Judith K. Wolf, Winnie Polen, Stephen R. Grobmyer, Karthik Ghosh, Donald W. Northfelt, Karen Baker, Haythem Ali, Nitin Rohatgi, Carrie Costantini, Josie Alpers, Karen S. Anderson, Joshua LaBaer, Ana P. Lourenco, David E. Reese, Rao Mulpuri, Elias E. Letsios, Quynh Tran, Michael Silver, Meredith C. Henderson
Rok vydání: 2023
DOI: 10.1158/1078-0432.22473977.v1
Popis: Table S1. Enrollment Criteria Table S2. Enrollment Sites Table S3. Serum protein biomarkers (SPB) and tumor-associated autoantibodies (TAAb) evaluated in the current study. Table S4: Clinical conditions and criteria for inclusion. Table S5: Comparison of biomarker measurements between women divided by age and by FSH. Table S6: Clinical performance of Videssa Breast in all samples categorized by breast density (dense: categories a and b, non-dense: categories c and d) and by health exclusion. Table S7: Clinical performance of Videssa Breast in subjects ages 25-49.
Databáze: OpenAIRE